Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
07 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250606873555/en/Otsuka-Sibeprenlimab-Phase-3-Data-Show-a-Statistically-Significant-and-Clinically-Meaningful-Proteinuria-Reduction-for-the-Treatment-of-Immunoglobulin-A-Nephropathy-IgAN
27 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250527959047/en/Otsuka-Announces-FDA-Acceptance-and-Priority-Review-of-Biologics-License-Application-BLA-for-Sibeprenlimab-in-the-Treatment-of-Immunoglobulin-A-Nephropathy-IgAN
05 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fangzhou-launches-otsukas-third-generation-leukemia-drug-ponatinib-on-its-platform-302446583.html
24 Apr 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/mosaic-adds-cancer-combo-pattern-licensing-2-clinical-stage-drugs-astex
31 Mar 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250331152906/en/Otsuka-Files-Biologics-License-Application-BLA-for-Sibeprenlimab-in-the-Treatment-of-Immunoglobulin-A-Nephropathy
19 Nov 2024
// BUSINESSWIRE
ABOUT THIS PAGE
Otsuka Pharmaceutical is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of Aripiprazole bulk offered by Otsuka Pharmaceutical
Find a price of Brexpiprazole bulk offered by Otsuka Pharmaceutical
Find a price of Tolvaptan bulk offered by Otsuka Pharmaceutical